Facile generation of heterotelechelic poly(2‐oxazoline)s towards accelerated exploration of poly(2‐oxazoline)‐based nanomedicine

Joachim F. R. Van Guyse,Saed Abbasi,Kazuko Toh,Zlata Nagorna,Junjie Li,Anjaneyulu Dirisala,Sabina Quader,Satoshi Uchida,Kazunori Kataoka
DOI: https://doi.org/10.1002/anie.202404972
2024-04-25
Angewandte Chemie International Edition
Abstract:Controlling the end-groups of biocompatible polymers is crucial for enabling polymer-based therapeutics and nanomedicine. Typically, end-group diversification is a challenging and time-consuming endeavor, especially for polymers pre-pared via ionic polymerization mechanisms with limited functional group tolerance. In this study, we present a facile end-group diversification approach for poly(2-oxazoline)s (POx), enabling quick and reliable production of hetero-telechelic polymers to facilitate POxylation. The approach relies on the careful tuning of reaction parameters to establish differential reactivity of a pentafluorobenzyl initiator fragment and the living oxazolinium chain-end, allowing the selective introduction of N-, S-, O-nucleophiles via the termination of the polymerization, and a consecutive nucleophilic para-fluoro substitution. The value of this approach for the accelerated development of nanomedicine is demonstrated through the synthesis of well-defined lipid-polymer conjugates and POx-polypeptide block-copolymers, which are well-suited for drug and gene delivery. Furthermore, we investigated the application of a lipid-POx conjugate for the formulation and delivery of mRNA-loaded lipid nanoparticles for immunization against the SARS-COV-2 virus, underscoring the value of POx as a biocompatible polymer platform.
chemistry, multidisciplinary
What problem does this paper attempt to address?